Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism 17β-HSD5 inhibitors(Aldo-keto-reductase family 1 member C3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced cancer | Phase 2 | CN | 05 Jun 2022 | |
Advanced Malignant Solid Neoplasm | Phase 2 | CN | 05 Jun 2022 | |
Hematologic Neoplasms | IND Approval | CN | 14 Jul 2023 | |
Solid tumor | Preclinical | CN | 15 Jun 2022 | |
Solid tumor | Preclinical | CN | 15 Jun 2022 |